普洛药业(000739.SZ)：阿莫西林克拉维酸钾片获得药品注册证书

Core Viewpoint - Prolo Pharmaceutical (000739.SZ) announced that its wholly-owned subsidiary, Zhejiang Prolo Jutai Pharmaceutical Co., Ltd., has received a drug registration certificate for Amoxicillin and Clavulanate Potassium Tablets from the National Medical Products Administration [1] Group 1: Product Information - The product is indicated for the treatment of various infections, including upper respiratory infections (such as recurrent tonsillitis, sinusitis, and otitis media) [1] - It is also used for lower respiratory infections, particularly acute and chronic bronchitis (especially for severe infections), lobar pneumonia, and bronchopneumonia [1] - Additionally, it treats urinary system infections like cystitis (especially recurrent or complicated infections, excluding prostatitis) [1] - The product is effective for skin and soft tissue infections, such as cellulitis and infections from animal bites [1] - It is indicated for oral infections, including severe gingival abscesses combined with facial cellulitis [1]